HeartBeam Inc BEAT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BEAT is a good fit for your portfolio.
News
-
HeartBeam Reports Third Quarter 2023 Financial Results
-
HeartBeam Announces Expansion of Its Scientific Advisory Board
-
HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
-
HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time
-
Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer
-
HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team
-
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
Trading Information
- Previous Close Price
- $1.45
- Day Range
- $1.43–1.50
- 52-Week Range
- $1.11–6.00
- Bid/Ask
- $1.45 / $1.47
- Market Cap
- $38.70 Mil
- Volume/Avg
- 31,971 / 56,119
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
HeartBeam Inc is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Its initial focus is providing diagnostic data to help physicians with the care management of patients with cardiovascular disease.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- —
- Total Number of Employees
- 13
- Website
- https://www.heartbeam.com
Valuation
|
Metric
|
BEAT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.05 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BEAT
|
|---|---|
Quick Ratio | 18.83 |
Current Ratio | 19.12 |
Interest Coverage | — |
Quick Ratio
BEAT
Profitability
|
Metric
|
BEAT
|
|---|---|
Return on Assets (Normalized) | −113.23% |
Return on Equity (Normalized) | −128.92% |
Return on Invested Capital (Normalized) | −133.95% |
Return on Assets
BEAT
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | Vshsbgt | $30.9 Bil | |
VEEV
| Veeva Systems Inc Class A | Hbmnj | $28.6 Bil | |
MTHRF
| M3 Inc | Wyk | $10.5 Bil | |
MTHRY
| M3 Inc ADR | Kmjr | $10.5 Bil | |
PMCUF
| Pro Medicus Ltd | Lrpqsb | $6.2 Bil | |
HQY
| HealthEquity Inc | Wqjqhc | $5.9 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | Pvwxw | $5.4 Bil | |
RCM
| R1 RCM Inc | Zmqw | $4.6 Bil | |
DOCS
| Doximity Inc Class A | Zzvcj | $4.4 Bil | |
PGNY
| Progyny Inc | Pzstpl | $3.4 Bil |